Takeda Pharmaceutical
92 hedge funds and large institutions have $910M invested in Takeda Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+76
Holders Change %
+475%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
83
Increased
1
Reduced
6
Closed
7
Calls
$7.49M
Puts
$4.34M
Net Calls
+$3.14M
Net Calls Change
+$3.14M
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
+$171M |
2 |
Bank of America
Charlotte,
North Carolina
|
+$116M |
3 |
Citigroup
New York
|
+$113M |
4 |
Goldman Sachs
New York
|
+$85.8M |
5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$63.4M |